Great to see you at FT Live

Thanks for visiting Mazars at the FT Live: Global Pharma & Biotech Summit. It was great to meet you and we hope you enjoyed your special ‘Mazars edition’ Tony’s Chocolonely bar.

At Mazars, we are committed to supporting the pharma and life sciences sector – helping companies navigate disruption, embrace innovation and grow with confidence. You can browse a selection of our latest sector insights and expert analysis by our dedicated team here.

For more information or to sign up for the latest pharma & life sciences news and insights, please get in touch.

Anti-bribery and corruption in the sector

Nigel Layton, our Global Head of Pharma & Life Sciences and UK Head of Investigations, gives his insight on anti-bribery and corruption within the pharma and life sciences sector.

Private equity and deals activity in the sector

05/10/2023. Tarifa Simpson, our Healthcare & Life Sciences Co-Lead and Due Diligence Partner, gives her views on the current deals environment within the healthcare and life sciences sector.

Conducting an effective internal investigation

As companies face increasing scrutiny and an aggressive drive to criminalise corporate misconduct, there has been a marked increase in firms conducting internal investigations. Nigel Layton, our Head of Investigations and Global Head of Pharma & Life Sciences, explains the key components of a successful internal investigation.

Bringing the ‘E’ and the ’S’ together

Acting on the principles embodied in ESG (environmental, social and governance) is fraught with difficulty.

Apprenticeship Levy FAQs

06/02/23. Employing apprentices is nothing new. It has been in place for hundreds of years, in various forms. However, one of the biggest changes in a generation took place in April 2017 as the Apprenticeship Levy was introduced to give employers more control over how they govern and control training costs.